281 related articles for article (PubMed ID: 8247540)
21. Trans-activation of heparanase promoter by ETS transcription factors.
Lu WC; Liu YN; Kang BB; Chen JH
Oncogene; 2003 Feb; 22(6):919-23. PubMed ID: 12584571
[TBL] [Abstract][Full Text] [Related]
22. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
Soldatenkov VA; Albor A; Patel BK; Dreszer R; Dritschilo A; Notario V
Oncogene; 1999 Jul; 18(27):3954-62. PubMed ID: 10435618
[TBL] [Abstract][Full Text] [Related]
24. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
[TBL] [Abstract][Full Text] [Related]
25. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
[TBL] [Abstract][Full Text] [Related]
26. Role of ETS1 in IL-2 gene expression.
Romano-Spica V; Georgiou P; Suzuki H; Papas TS; Bhat NK
J Immunol; 1995 Mar; 154(6):2724-32. PubMed ID: 7876544
[TBL] [Abstract][Full Text] [Related]
27. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
Lynch CC; Crawford HC; Matrisian LM; McDonnell S
Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
[TBL] [Abstract][Full Text] [Related]
29. Expression of angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements.
Hegen A; Koidl S; Weindel K; Marmé D; Augustin HG; Fiedler U
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1803-9. PubMed ID: 15284088
[TBL] [Abstract][Full Text] [Related]
30. Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells.
Cron RQ; Zhou B; Brunvand MW; Lewis DB
Genes Immun; 2001 Dec; 2(8):464-8. PubMed ID: 11781715
[TBL] [Abstract][Full Text] [Related]
31. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.
Wasylyk B; Wasylyk C; Flores P; Begue A; Leprince D; Stehelin D
Nature; 1990 Jul; 346(6280):191-3. PubMed ID: 2114554
[TBL] [Abstract][Full Text] [Related]
32. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
Li R; Pei H; Watson DK; Papas TS
Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
[TBL] [Abstract][Full Text] [Related]
33. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
34. A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes.
Wang J; Shannon MF; Young IG
Int Immunol; 2006 Feb; 18(2):313-23. PubMed ID: 16373364
[TBL] [Abstract][Full Text] [Related]
35. A B-cell coactivator of octamer-binding transcription factors.
Gstaiger M; Knoepfel L; Georgiev O; Schaffner W; Hovens CM
Nature; 1995 Jan; 373(6512):360-2. PubMed ID: 7779176
[TBL] [Abstract][Full Text] [Related]
36. Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors.
Kistler B; Pfisterer P; Wirth T
Oncogene; 1995 Sep; 11(6):1095-106. PubMed ID: 7566969
[TBL] [Abstract][Full Text] [Related]
37. Ets1, when fused to the GAL4 DNA binding domain, efficiently enhances galactose promotor dependent gene expression in yeast.
Seneca S; Punyammalee B; Bailly M; Ghysdael J; Crabeel M
Oncogene; 1991 Mar; 6(3):357-60. PubMed ID: 1901401
[TBL] [Abstract][Full Text] [Related]
38. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises.
Pognonec P; Boulukos KE; Bosselut R; Boyer C; Schmitt-Verhulst AM; Ghysdael J
Oncogene; 1990 Apr; 5(4):603-10. PubMed ID: 2183162
[TBL] [Abstract][Full Text] [Related]
39. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene.
Kopp JL; Wilder PJ; Desler M; Kim JH; Hou J; Nowling T; Rizzino A
J Biol Chem; 2004 May; 279(19):19407-20. PubMed ID: 14976186
[TBL] [Abstract][Full Text] [Related]
40. Sequence specific binding of Ets-1 to the mouse cytokeratin EndoA gene enhancer.
Hamazato F; Fujimura Y; Tamai Y; Takemoto Y; Matsushiro A; Nozaki M
Biochem Biophys Res Commun; 1993 Apr; 192(2):430-8. PubMed ID: 7683460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
